Alternatives to Sherman Diagnostics

Harnessing genetic data for digital insights in rare and germline disorders.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Develops a computational model of the human body for drug discovery and development.

AI-powered spatial biology platform for precision medicine and drug development.

Developing genetic medicines and cell therapies for severe diseases using proprietary CRISPR OMNI technology.

Precision oncology company developing cancer therapies guided by proprietary functional genomics.

Biotech company using AI and deep RNA analysis to predict cancer treatment response.

Leveraging proteomic pattern analysis to personalize cancer treatment and improve patient outcomes.

Developing a liquid biopsy blood test for early disease detection and monitoring using epigenetic information.

Scent-based multi-cancer early detection screening test using AI and bio-detectors.

Developing novel diagnostics to predict patient response to immunotherapy.

Biotechnology company developing inhaled therapies for genetic diseases, focusing on Cystic Fibrosis.

Leveraging the adaptive immune system to diagnose and treat disease.

Global life sciences company providing diagnostic and biopharma laboratory services.

Integrates scientific big data with patient medical records for personalized disease models and AI-driven insights.

Transforming healthcare by turning scientific fiction into scientific facts.

AI-powered blood analysis for precise substance tracing and classification in healthcare and research.

Microbiome technology platform for developing novel therapeutics.

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.